Oligosaccharides as Potential Therapeutics against Atherosclerosis

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Pharmacology

Background:

• Atherosclerosis, driven by cholesterol accumulation and inflammation, is a primary cause of global cardiovascular mortality.
• Increasing rates of obesity, diabetes, and hyperlipidemia necessitate novel, cost-effective atherosclerosis therapies.
• Oligosaccharides are abundant, inexpensive, and have established roles in various biomedical applications.

Purpose of the Study:

• To review current knowledge on oligosaccharides in atherosclerosis research.
• To update on recent in vitro and in vivo studies preceding clinical trials.
• To highlight the therapeutic potential of oligosaccharides for atherosclerosis.

Main Methods:

• Review of existing literature on oligosaccharides and atherosclerosis.
• Analysis of in vitro experimental data.
• Evaluation of in vivo study findings.

Main Results:

• Oligosaccharides demonstrate potential in managing lipoprotein-derived cholesterol accumulation.
• Evidence suggests oligosaccharides can modulate chronic inflammation associated with atherosclerosis.
• Pre-clinical studies indicate efficacy in slowing atherosclerotic plaque development.

Conclusions:

• Oligosaccharides represent a promising, cost-effective therapeutic avenue for atherosclerosis.
• They may reduce residual cardiovascular risk when used alongside conventional lipid-lowering drugs.
• Further clinical investigation is warranted to establish oligosaccharides as a viable treatment for atherosclerosis.